Cargando…

Dihydromyricetin Attenuates TNF-α-Induced Endothelial Dysfunction through miR-21-Mediated DDAH1/ADMA/NO Signal Pathway

Accumulating studies demonstrate that dihydromyricetin (DMY), a compound extracted from Chinese traditional herb, Ampelopsis grossedentata, attenuates atherosclerotic process by improvement of endothelial dysfunction. However, the underlying mechanism remains poorly understood. Thus, the aim of this...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yang, Dafeng, Tan, Shenglan, Yang, Zhousheng, Jiang, Pei, Qin, Caie, Yuan, Qiong, Dang, Ruili, Yao, Xiaoxia, Qu, Jian, Lu, Qiong, Xu, Ping, Zhang, Bikui, Xiang, Daxiong, Chen, Lei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5850903/ https://www.ncbi.nlm.nih.gov/pubmed/29682517 http://dx.doi.org/10.1155/2018/1047810

Ejemplares similares

DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats
por: Zhu, Zhen-Dong, et al.
Publicado: (2019)

Dihydromyricetin increases endothelial nitric oxide production and inhibits atherosclerosis through microRNA‐21 in apolipoprotein E‐deficient mice
por: Yang, Dafeng, et al.
Publicado: (2020)

Sequence Variation in DDAH1 and DDAH2 Genes Is Strongly and Additively Associated with Serum ADMA Concentrations in Individuals with Type 2 Diabetes
por: Abhary, Sotoodeh, et al.
Publicado: (2010)

Association of Variability in the DDAH1, DDAH2, AGXT2 and PRMT1 Genes with Circulating ADMA Concentration in Human Whole Blood
por: Hannemann, Juliane, et al.
Publicado: (2022)

Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway
por: Zhong, Ying, et al.
Publicado: (2022)

Erratum to “Inhibition of miR-21 improves pulmonary vascular responses in bronchopulmonary dysplasia by targeting the DDAH1/ADMA/NO pathway”
por: Zhong, Ying, et al.
Publicado: (2023)

Changes in ADMA/DDAH Pathway after Hepatic Ischemia/Reperfusion Injury in Rats: The Role of Bile
por: Ferrigno, Andrea, et al.
Publicado: (2014)

N-Acetylcysteine Prevents Hypertension via Regulation of the ADMA-DDAH Pathway in Young Spontaneously Hypertensive Rats
por: Fan, Nai-Chia, et al.
Publicado: (2013)

Chitosan oligosaccharide ameliorates acute lung injury induced by blast injury through the DDAH1/ADMA pathway
por: Liu, Yun-En, et al.
Publicado: (2018)

Metabolite asymmetric dimethylarginine (ADMA) functions as a destabilization enhancer of SOX9 mediated by DDAH1 in osteoarthritis
por: Wu, Yizheng, et al.
Publicado: (2023)

Impact of High Salt Independent of Blood Pressure on PRMT/ADMA/DDAH Pathway in the Aorta of Dahl Salt-Sensitive Rats
por: Cao, Yu, et al.
Publicado: (2013)

Evaluation of ADMA-DDAH-NOS axis in specific brain areas following nitroglycerin administration: study in an animal model of migraine
por: Greco, Rosaria, et al.
Publicado: (2015)

DDAH1/ADMA Regulates Adiponectin Resistance in Cerebral Ischemia via the ROS/FOXO1/APR1 Pathway
por: Zhao, Yichen, et al.
Publicado: (2022)

Blond and blood juice supplementation in high fat diet fed mice: effect on antioxidant status and DDAH/ADMA pathway
por: Sorrenti, V., et al.
Publicado: (2019)

Dihydromyricetin Inhibits M1 Macrophage Polarization in Atherosclerosis by Modulating miR-9-Mediated SIRT1/NF-κB Signaling Pathway
por: Yang, Zhousheng, et al.
Publicado: (2023)

A Novel Role of Irbesartan in Gastroprotection against Indomethacin-Induced Gastric Injury in Rats: Targeting DDAH/ADMA and EGFR/ERK Signaling
por: Shahin, Nancy N., et al.
Publicado: (2018)

Epigallocatechin-3-gallate ameliorates erectile function in aged rats via regulation of PRMT1/DDAH/ADMA/NOS metabolism pathway
por: Chen, Dong, et al.
Publicado: (2017)

Dietary Supplementation of Caulerpa racemosa Ameliorates Cardiometabolic Syndrome via Regulation of PRMT-1/DDAH/ADMA Pathway and Gut Microbiome in Mice
por: Nurkolis, Fahrul, et al.
Publicado: (2023)

Cysteine-Rich Whey Protein Isolate (CR-WPI) Ameliorates Erectile Dysfunction by Diminishing Oxidative Stress via DDAH/ADMA/NOS Pathway
por: Li, Kefan, et al.
Publicado: (2022)

DDAH1 Deficiency Attenuates Endothelial Cell Cycle Progression and Angiogenesis
por: Zhang, Ping, et al.
Publicado: (2013)

Dimethylarginine Dimethylaminohydrolase 2 (DDAH 2) Gene Polymorphism, Asymmetric Dimethylarginine (ADMA) Concentrations, and Risk of Coronary Artery Disease: A Case-Control Study
por: Xuan, Chao, et al.
Publicado: (2016)

Involvement of DDAH/ADMA/NOS/cGMP and COX-2/PTGIS/cAMP Pathways in Human Tissue Kallikrein 1 Protecting Erectile Function in Aged Rats
por: Cui, Kai, et al.
Publicado: (2017)

Sulfated Polysaccharide from Caulerpa racemosa Attenuates the Obesity-Induced Cardiometabolic Syndrome via Regulating the PRMT1-DDAH-ADMA with mTOR-SIRT1-AMPK Pathways and Gut Microbiota Modulation
por: Mayulu, Nelly, et al.
Publicado: (2023)

Assessment of DDAH1 and DDAH2 Contributions to Psychiatric Disorders via In Silico Methods
por: Kozlova, Alena A., et al.
Publicado: (2022)

Mechanism of Dihydromyricetin on Inflammatory Diseases
por: Sun, Yang, et al.
Publicado: (2022)

Inhibition of DDAH1, but not DDAH2, results in apoptosis of a human trophoblast cell line in response to TRAIL
por: Lumicisi, B.A., et al.
Publicado: (2015)

The Versatile Effects of Dihydromyricetin in Health
por: Li, Hongliang, et al.
Publicado: (2017)

Effects of ADMA upon Gene Expression: An Insight into the Pathophysiological Significance of Raised Plasma ADMA
por: Smith, Caroline L, et al.
Publicado: (2005)

Upregulation of DDAH2 Limits Pulmonary Hypertension and Right Ventricular Hypertrophy During Chronic Hypoxia in Ddah1 Knockout Mice
por: Hannemann, Juliane, et al.
Publicado: (2020)

Association between variation in the genes DDAH1 and DDAH2 and hypertension among Uygur, Kazakh and Han ethnic groups in China: Associação entre variação de genes DDAH1 e DDAH2 com hipertensão nos grupos étnicos uygur, kazakh e han na China
por: Wang, Zhong, et al.
Publicado: (2016)

Dihydromyricetin Attenuates Inflammation through TLR4/NF-kappaB Pathway
por: Jing, Nianshui, et al.
Publicado: (2019)

Asymmetric Dimethylarginine (ADMA) and Endothelial Dysfunction: Implications for Atherogenesis
por: Landim, Maurício Batista Paes, et al.
Publicado: (2009)

Dihydromyricetin hexaacetate
por: Li, Wei, et al.
Publicado: (2010)

Research progress of dihydromyricetin in the treatment of diabetes mellitus
por: Wang, Ziyuan, et al.
Publicado: (2023)

Retraction on “Dihydromyricetin attenuates inflammation through TLR4/NF-kappa B pathway”
por: Jing, Nianshui, et al.
Publicado: (2021)

Dihydromyricetin Attenuates Depressive-like Behaviors in Mice by Inhibiting the AGE-RAGE Signaling Pathway
por: Huang, Jun, et al.
Publicado: (2022)

Recent Update on the Pharmacological Effects and Mechanisms of Dihydromyricetin
por: Zhang, Jingyao, et al.
Publicado: (2018)

Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes
por: Tsikas, Dimitrios, et al.
Publicado: (2018)

The Role of Asymmetric Dimethylarginine (ADMA) in Endothelial Dysfunction and Cardiovascular Disease
por: Sibal, Latika, et al.
Publicado: (2010)

The Endothelial ADMA/NO Pathway in Hypoxia-Related Chronic Respiratory Diseases
por: Lüneburg, Nicole, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_9c8l4ua1ponh73ookpvhqu1r3o